Pilot Phase II Trial of Bevacizumab Monotherapy in Nonmetastatic Castrate-Resistant Prostate Cancer

Por Ogita, Shin, Tejwani, Sheela, Heilbrun, Lance, Fontana, Joseph, Heath, Elisabeth, Freeman, Stacy, Smith, Daryn, Baranowski, Karen, Vaishampayan, Ulka
Publicado em 2012

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Por Marur, Shanthi, Eliason, James, Heilbrun, Lance K., Dickow, Brenda, Smith, Daryn W., Baranowski, Karen, Alhasan, Samir, Vaishampayan, Ulka
Publicado em 2008

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase II...

Por Unger, Joseph M., Griffin, Katherine, Donaldson, Gary W., Baranowski, Karen M., Good, Margorie J., Reburiano, Eunicia, Hussain, Maha, Monk, Paul J., Van Veldhuizen, Peter J., Carducci, Michael A., Higano, Celestia S., Lara, Primo N., Tangen, Catherine M., Quinn, David I., Wade, James L., III, Vogelzang, Nicholas J., Thompson, Ian M., Jr, Moinpour, Carol M.
Publicado no J Patient Rep Outcomes (2018)